Queen moves in PDL chess game

Cary Queen, the co-founder of PDL Biopharma Inc., has stepped into the debate over corporate strategy at PDLI, aligning himself with hedge fund Third Point's campaign to oust CEO Mark McDade.

Queen was with PDLI for 15 years, primarily as head of its research department and then as a director. In February 2006 he became a consultant to the antibody company. ...